Role of allogeneic stem cell transplantation in mantle cell lymphoma.

about

Functional screen identifies regulators of murine hematopoietic stem cell repopulation

P2860

Q36745020-67E7E3DC-D27C-472A-921B-BCBBC3C13C0A

P2860

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q38242980

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

@en

type

Item

label

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

@en

prefLabel

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

@en

P1476

Role of allogeneic stem cell transplantation in mantle cell lymphoma

@en

P2093

Jonathon B Cohen

http://www.w3.org/2001/XMLSchema#string

Linda J Burns

http://www.w3.org/2001/XMLSchema#string

P2860

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.

Treatment of older patients with mantle-cell lymphoma.

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.

P304

290-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12442

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Veronika Bachanova

P577

2014-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265053460

http://www.w3.org/2001/XMLSchema#string

P698

25154430

http://www.w3.org/2001/XMLSchema#string

P932

5575931

http://www.w3.org/2001/XMLSchema#string

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

about

P2860

P2860

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932